Control Bionics is excited to announce the expansion of our management team with Vice President – North America, Todd Tyler. Tyler brings over 20 years of healthcare experience in a variety of roles: from a speech-language pathologist and sales representative, to...
We’re changing our look, but not our mission to become the world’s leading provider of innovative augmentative communication and control devices for people with speech and movement disabilities. For the last 15 years, Control Bionics has been dedicated to our clients,...
CEO Rob Wong sat down with the podcast Fear and Greed this week to discuss how Control Bionics helps patients with some of the most debilitating conditions to communicate. They dove into the history of Control Bionics, an explanation of the technology, and how the...
As a regular contributor of Biotech Daily, which provides news on ASX-listed biotechnology companies, Dr. Boreham’s Crucible provides analysis of the biotech sector in Australia. Last week Control Bionics was featured in an article on the site. Access the Full...
Rob-Wong-Alan-Kohler-–-Eureka-Report Rob Wong, CEO of Control Bionics, chats with Alan Kohler from Eureka Report to discuss the latest news from the newly ASX-listed business. ” … the fundamental point about that was that your brain sends very, very fast signals...
Medtech company Control Bionics (ASX:CBL) will list on the ASX next week. The company’s EMG (electromyography)-based technology helps people with disabilities inhibiting communications to do so through electronic devices that pick up their neuroelectric...
